ALB and hepatocellular carcinoma: Studies conducted by Liao et al. [135] and Zhang et al. [136] revealed that a high score or grade of a pre-treatment serum ALB–BIL combined with pre-treatment fibrosis-4 (FIB-4) score was independently correlated with worse OS and RFS in HCC patients undergoing curative surgical resection.